Impact of monoclonal anti-CD38 antibody on collected myeloid and erythroid progenitor cells and clinical course of autologous stem cell transplant for patients with multiple myeloma

被引：0
|
作者：
Manjappa, Shivaprasad [1 ]
Eduafo, Augusta [2 ]
Fox, Robert [1 ]
Reese, Jane [1 ]
Schmikla, Hannah [1 ]
Kolk, Merle [1 ]
Driscoll, James [1 ]
Malek, Ehsan [3 ]
机构：
[1] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA
[2] St Johns Med Ctr, Westlake, OH USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-026
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [31] Real-world treatment patterns and clinical outcomes amongst patients with relapsed/refractory multiple myeloma previously treated with lenalidomide and an anti-CD38 monoclonal antibody
    Cowan, Andrew
    Katz, Jessica
    Ho, Carrie
    Gu, Tao
    Marshall, Thomas
    Gu, Fangyi
    Tang, Yuexin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S169 - S169
  • [32] Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes
    Xavier Leleu
    Thomas Martin
    Katja Weisel
    Fredrik Schjesvold
    Shinsuke Iida
    Fabio Malavasi
    Salomon Manier
    Enrique M. Chang-Ki Min
    Charlotte Ocio
    Aurore Pawlyn
    Hang Perrot
    Joshua Quach
    Ivan Richter
    Kwee Spicka
    Paul G. Yong
    Annals of Hematology, 2022, 101 : 2123 - 2137
  • [33] Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes
    Leleu, Xavier
    Martin, Thomas
    Weisel, Katja
    Schjesvold, Fredrik
    Iida, Shinsuke
    Malavasi, Fabio
    Manier, Salomon
    Min, Chang-Ki
    Ocio, Enrique M.
    Pawlyn, Charlotte
    Perrot, Aurore
    Quach, Hang
    Richter, Joshua
    Spicka, Ivan
    Yong, Kwee
    Richardson, Paul G.
    ANNALS OF HEMATOLOGY, 2022, 101 (10) : 2123 - 2137
  • [34] Modulation of CD38 Expression Levels on Multiple Myeloma Tumor Cells By All-Trans Retinoic Acid Improves the Efficacy of the Anti-CD38 Monoclonal Antibody Daratumumab
    Nijhof, Inger S.
    Lokhorst, Henk M.
    van Kessel, Berris
    Groen, Richard W. J.
    Martens, Anton C.
    Doshi, Parul
    Klein, Saskia K.
    Mutis, Tuna
    Sasser, Kate
    van de Donk, Niels W. C. J.
    BLOOD, 2014, 124 (21)
  • [35] Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies
    Schiller, Gary J.
    Lipe, Brea C.
    Bahlis, Nizar J.
    Tuchman, Sascha A.
    Bensinger, William I.
    Sutherland, Heather J.
    Lentzsch, Suzanne
    Baljevic, Muhamed
    White, Darrell
    Kotb, Rami
    Chen, Christine I.
    Rossi, Adriana
    Biran, Noa
    Leblanc, Richard
    Grosicki, Sebastian
    Martelli, Maurizio
    Gunsilius, Eberhard
    Spicka, Ivan
    Stevens, Don Ambrose
    Facon, Thierry
    Mesa, Mercedes Gironella
    Zhang, Chris
    Domelen, Dane R. Van
    Bentur, Ohad S.
    Gasparetto, Cristina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (09): : e286 - e296.e4
  • [36] Natural History of Patients with Multiple Myeloma Refractory to Elotuzumab and Outcomes of Subsequent Therapy with Anti-CD38 Monoclonal Antibodies
    Varnado, William
    Jagosky, Megan Helena
    Gahvari, Zhubin
    Chhabra, Saurabh
    Gandhi, Ujjawal H.
    Lakshman, Arjun
    McGehee, Elizabeth
    Gupta, Ridhi
    Malek, Ehsan
    Fiala, Mark A.
    Mansour, Joshua
    Paul, Barry
    Barnstead, Alyssa
    Kodali, Saranya
    Amarendra, Neppalli
    Liedtke, Michaela
    Godby, Kelly N.
    Kang, Yubin
    Kansgra, Ankit
    Scott, Emma C.
    Umyarova, Elvira
    Hari, Parameswaran
    Vij, Ravi
    Usmani, Saad Z.
    Cornell, Robert Frank
    Kumar, Shaji K.
    Callander, Natalie Scott
    Costa, Luciano J.
    BLOOD, 2018, 132
  • [37] Retrospective Analysis of Response Rates to Anti-CD38 Monoclonal Antibody Containing Regimens Among Multiple Myeloma Patients with Prior Exposure to Daratumumab or Isatuximab
    Yashar, David
    Regidor, Bernard Sean S.
    Jew, Scott Kristian
    Bujarski, Sean
    Goldwater, Marissa-Skye
    Swift, Regina
    Schwartz, Gary Edward
    Eshaghian, Shahrooz
    Vescio, Robert
    Berenson, James R.
    BLOOD, 2021, 138 : 3785 - +
  • [38] Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials
    de Moraes, Francisco Cezar Aquino
    Sano, Vitor Kendi Tsuchiya
    Lobo, Artur de Oliveira Macena
    Kelly, Francinny Alves
    Morbach, Victoria
    Pasqualotto, Eric
    Burbano, Rommel Mario Rodriguez
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (04):
  • [39] The Anti-CD38 Monoclonal Antibody TAK-079 Depletes Antibody Secreting Cells from Normal and SLE Patients
    Wang, Xiaoqian
    Dahl, Martin
    Nguyen, Doan
    Jenks, Scott
    Cashman, Kevin
    Lee, F. Eun-Hyung
    McLean, Lachy
    Sanz, Ignacio
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [40] Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma
    Bao, Alicia
    Zhao, Qiuhong
    Kudalkar, Ruchi
    Rodriguez, Jose
    Sharma, Nidhi
    Bumma, Naresh
    Devarakonda, Srinivas S.
    Khan, Abdullah M.
    Umyarova, Elvira
    Rosko, Ashley E.
    Benson, Don
    Cottini, Francesca
    FRONTIERS IN ONCOLOGY, 2023, 13
12345